Ethosuximide and valproate display high efficacy against lindane-induced seizures in mice

Toxicology Letters

Volumn 154, Issue 1-2, 2004, Pages 55-60

  Kaminski, Rafal M ^a,c   Tochman, Anna M ^a   Dekundy, Andrzej ^a   Turski, Waldemar A ^a,b   Czuczwar, Stanislaw J ^a,b  

^a INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Ethosuximide; Lindane; Mice; Pentylenetetrazol; Seizures; Valproate

Indexed keywords

ETHOSUXIMIDE; LINDANE; PENTETRAZOLE; VALPROIC ACID;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE; TREATMENT OUTCOME;

ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; ETHOSUXIMIDE; GABA AGENTS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; LINDANE; MALE; MICE; PENTYLENETETRAZOLE; SEIZURES; VALPROIC ACID;

EID: 4744376137     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2004.07.002     Document Type: Article

References (35)

1. S.E. Aks, A. Krantz, D.O. Hryhrczuk, S. Wagner, and J. Mock Acute accidental lindane ingestion in toddlers Ann. Emerg. Med. 26 1995 647 651
2. R.E. Appleton, and A. Gill Adverse events associated with intravenous phenytoin in children: a prospective study Seizure 12 2003 369 372
3. P. Blaszczak, and W.A. Turski Excitatory amino acid antagonists alleviate convulsive and toxic properties of lindane in mice Pharmacol. Toxicol. 82 1998 137 141
4. M. Buffet, and N. Dupin Current treatments for scabies Fundam. Clin. Pharmacol. 17 2003 217 225
5. D.A. Coulter, J.R. Huguenard, and D.A. Prince Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons Ann. Neurol. 25 1989 582 593
6. V. Crunelli, and N. Leresche Block of thalamic T-type C2+ channels by ethosuximide is not the whole story Epilepsy Curr. 2 2002 53 56
7. S.J. Czuczwar, M. Gasior, R. Kaminski, Z. Kleinrok, M. Kozicka, G. Ossowska, and T. Pietrasiewicz GYKI 52466 [1-(4-aminophenyl)-4-methoxy-7,8- methylenedioxy-5H-2,3-benzodiazepine hydrochloride] and the anticonvulsive activity of conventional antiepileptics against pentetrazol in mice Mol. Chem. Neuropathol. 33 1998 149 162
8. S.J. Czuczwar, and P.N. Patsalos The new generation of GABA enhancers. Potential in the treatment of epilepsy CNS Drugs 15 2001 339 350
9. F.E. Dreifuss Ethosuximide toxicity R.H. Levy R.H. Mattson B.S. Meldrum Antiepileptic Drugs 1995 Raven Press New York, USA 675 679
10. FDA Labeling changes for Lindane FDA Consum. 37 2003 6
11. J.A. Ferrendelli, and K.D. Holland Ethosuximide mechanism of action R.H. Levy R.H. Mattson B.S. Meldrum Antiepileptic Drugs 1995 Raven Press New York, USA 649 654
12. T.F. Fischer Lindane toxicity in a 24-year-old woman Ann. Emerg. Med. 24 1994 972 974
13. B.E. Fishman, and G. Gianutsos CNS biochemical and pharmacological effects of the isomers of hexachlorocyclohexane (lindane) in the mouse Toxicol. Appl. Pharmacol. 93 1988 146 153
14. M.A. Howland Insecticides: chlorinated hydrocarbons, pyrethrins and DEET L.R. Goldfrank Goldfrank's Toxicologic Emergencies 1998 Appleton and Lange Stamford, CT, USA 1451 1458
15. R.Q. Huang, C.L. Bell-Horner, M.I. Dibas, D.F. Covey, J.A. Drewe, and G.H. Dillon Pentylenetetrazole-induced inhibition of recombinant gamma-aminobutyric acid type A (GABA(A)) receptors: mechanism and site of action J. Pharmacol. Exp. Ther. 298 2001 986 995
16. J.R. Huguenard Block of T-type C2+ channels is an important action of succinimide antiabsence drugs Epilepsy Curr. 2 2002 49 52
17. J.C. Konje, E.O. Otolorin, P.T. Sotunmbi, and O.A. Ladipo Insecticide poisoning in pregnancy. A case report J. Reprod. Med. 37 1992 992 994
18. N. Leresche, H.R. Parri, G. Erdemli, A. Guyon, J.P. Turner, S.R. Williams, E. Asprodini, and V. Crunelli On the action of the anti-absence drug ethosuximide in the rat and cat thalamus J. Neurosci. 18 1998 4842 4853
19. Y.F. Li Global technical hexachlorocyclohexane usage and contamination consequences in the environment: from 1948 to 1997 Sci. Total Environ. 232 1999 121 158
20. W. Loscher Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action Prog. Neurobiol. 58 1999 31 59
21. W. Loscher, D. Honack, C.P. Fassbender, and B. Nolting The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models Epilepsy Res. 8 1991 171 189
22. W. Loscher, and B. Nolting The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. IV. Protective indices Epilepsy Res. 9 1991 1 10
23. T. Narahashi Transmitter-activated ion channels as the target of chemical agents Adv. Exp. Med. Biol. 287 1991 61 73
24. S.P. Nordt, and G. Chew Acute lindane poisoning in three children J. Emerg. Med. 18 2000 51 53
25. E. Norris, O. Marzouk, A. Nunn, J. McIntyre, and I. Choonara Respiratory depression in children receiving diazepam for acute seizures: a prospective study Dev. Med. Child Neurol. 41 1999 340 343
26. E. Perucca Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience CNS Drugs 16 2002 695 714
27. A.K. Pramanik, and R.C. Hansen Transcutaneous gamma benzene hexachloride absorption and toxicity in infants and children Arch. Dermatol. 115 1979 1224 1225
28. M.A. Rogawski, and R.J. Porter Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds Pharmacol. Rev. 42 1990 223 286
29. U. Sayin, S. Cengiz, and T. Altug Vigabatrin as an anticonvulsant against pentylenetetrazol seizures Pharmacol. Res. 28 1993 325 331
30. W.A. Stewart, R. Harrison, and J.M. Dooley Respiratory depression in the acute management of seizures Arch. Dis. Child. 87 2002 225 226
31. M. Swiader, J. Luszczki, M. Wielosz, and S.J. Czuczwar Influence of vigabatrin, a novel antiepileptic drug, on the anticonvulsant activity of conventional antiepileptics in pentetrazole-induced seizures in mice Pol. J. Pharmacol. 55 2003 363 370
32. M. Tenenbein Seizures after lindane therapy J. Am. Geriatr. Soc. 39 1991 394 395
33. A.M. Tochman, R. Kaminski, W.A. Turski, and S.J. Czuczwar Protection by conventional and new antiepileptic drugs against lindane-induced seizures and lethal effects in mice Neurotox. Res. 2 2000 63 70
34. S. Yamaguchi, S.D. Donevan, and M.A. Rogawski Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBOX in maximal electroshock and chemoconvulsant seizure models Epilepsy Res. 15 1993 179 184
35. K.T. Yu, S. Mills, N. Thompson, and C. Cunanan Safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures Epilepsia 44 2003 724 726